At Cellbytes, our mission is to provide the ultimate AI companion for your diagnostic needs. Cellbytes is the first medical device to deliver a comprehensive cytomorphological assessment, including whole-slide analysis, cell classification, and dysplasia detection. Every algorithm is built on cutting-edge research and validated by robust scientific and clinical metrics.
Our team is deeply rooted in academia, constantly advancing the frontiers of deep learning and computational hematology. Our research explores the intricate connections between cell morphology, disease genetics, and clinical outcomes, with the goal of improving the understanding and management of blood disorders.
We're eager to collaborate with you on your research goals. Cellbytes's in-house R&D team has developed advanced algorithms for investigational use. Let us know how we can support your work and contribute to your discoveries.
Purhonen M, Tatun M, Luukkainen K, Hung K, Sundquist H, Tafjord O, Söderlund S, Adnan-Awad S, Dohlen A, Heikkinen J, Koskenvesa P, Siitonen S, Mustjoki S, Shanmuganathan N, Bryce C, Danielsson S, Hjorth-Hansen H, Olsson-Strömberg U, Kumagai T, Kimura S, Ross DM, Brück O
Leukemia / 16 Sep 2025
Ma J, Xie R, Ayyadhury S, Ge C, Gupta A, Gupta R, Gu S, Zhang Y, Lee G, Kim J, Lou W, Li H, Upschulte E, Dickscheid T, de Almeida JG, Wang Y, Han L, Yang X, Labagnara M, Gligorovski V, Scheder M, Rahi SJ, Kempster C, Pollitt A, Espinosa L, Mignot T, Middeke JM, Eckardt JN, Li W, Li Z, Cai X, Bai B, Greenwald NF, Van Valen D, Weisbart E, Cimini BA, Cheung T, Brück O, Bader GD, Wang B.
Nature Methods / 26 Mar 2024
